This startup is issuing AI-generated acne prescriptions

You can now get an AI-generated acne prescription for $4.99 a month, if you live in Utah.

Nolla Health, a healthcare startup, has launched a pilot program in Utah that uses artificial intelligence to generate prescriptions for acne treatment. Users in Utah can scan their faces using the Nolla Health app, and the AI system will analyze their acne severity to autonomously write a prescription. Initially, two physicians will approve each AI-generated prescription for the first 100 patients, after which physician review will occur post-prescription for up to 500 patients. Following this, physicians will review a minimum of 10% of monthly prescriptions, along with escalated cases or side effects. This service, costing $4.99 per month, is available to Utah residents aged 18 and older with mild-to-moderate acne and can prescribe eight different skin treatments. Nolla Health states this AI prescription service is intended to assist, not replace, physicians by handling routine cases, allowing dermatologists to focus on more complex patients.

Nolla Health's launch in Utah signifies a major step in the autonomous generation of initial medical prescriptions by AI, extending beyond the previously permitted renewals. This move, enabled by Utah's evolving regulatory landscape for AI in healthcare, positions Nolla Health as a pioneer in AI-driven direct-to-consumer medical treatment. The company's phased approach to physician oversight, starting with pre-approval and moving to post-prescription review and sampling, suggests a calculated strategy to balance innovation with patient safety and regulatory compliance.

The service's low monthly cost and focus on routine dermatological conditions like mild-to-moderate acne indicate a potential shift towards more accessible and affordable primary care solutions, particularly for common ailments. By aiming to handle low-acuity cases, Nolla Health seeks to alleviate pressure on specialist dermatologists, potentially reshaping how patients access and receive treatment for less severe conditions and demonstrating a viable model for other specialized AI healthcare applications.